B
Baird Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
776
Allbirds
BIRD
$49.1M
|
MA
Mark Altschwager
| $6.03 | $40 |
563%
upside
| Neutral |
10 Mar ‘23
2 years ago |
|
777
Ambarella
AMBA
$3.61B
|
TG
Tristan Gerra
| $84.64 | $120 |
42%
upside
| Outperform |
1 Mar ‘23
2 years ago |
|
778
Castle Biosciences
CSTL
$715M
|
CS
Catherine Schulte
| $24.65 | $38 |
54%
upside
| Outperform |
1 Mar ‘23
2 years ago |
|
779
Enovis
ENOV
$1.78B
|
JJ
Jeffrey Johnson
| $31.19 | $64 |
105%
upside
| Outperform |
24 Feb ‘23
2 years ago |
|
780
AMN Healthcare
AMN
$798M
|
MM
Mark Marcon
| $20.83 | $111 |
433%
upside
| Neutral |
17 Feb ‘23
2 years ago |
|
|
CHCT
781
Community Healthcare Trust
CHCT
$447M
|
BM
Bryan Maher
| $15.75 | $43 |
173%
upside
| Outperform |
16 Feb ‘23
2 years ago |
|
782
Arrowhead Research
ARWR
$3.83B
|
JB
Joel Beatty
| $27.73 | $58 |
109%
upside
| Outperform |
7 Feb ‘23
2 years ago |
|
783
Dover
DOV
$24B
|
MD
Mircea Dobre
| $174.68 | $165 |
6%
downside
| Outperform |
1 Feb ‘23
2 years ago |
|
784
SL Green Realty
SLG
$4.21B
|
DR
David Rodgers
| $59.28 | $43 |
27%
downside
| Neutral |
30 Jan ‘23
2 years ago |
|
785
Netflix
NFLX
$537B
|
WP
William Power
| $1,263.25 | $325 |
74%
downside
| Neutral |
20 Jan ‘23
2 years ago |
|
786
PNC Financial Services
PNC
$78.9B
|
DG
David George
| $200.41 | $205 |
2%
upside
| Outperform |
19 Jan ‘23
2 years ago |
|
|
INN
787
Summit Hotel Properties
INN
$608M
|
MB
Michael Bellisario
| $5.59 | $8 |
43%
upside
| Neutral |
12 Jan ‘23
2 years ago |
|
|
HPP
788
Hudson Pacific Properties
HPP
$1.11B
|
DR
Dave Rodgers
| $2.94 | $12 |
308%
upside
| Outperform |
6 Jan ‘23
2 years ago |
|
789
Vroom, Inc. Common Stock
VRM
$131M
|
CS
Colin Sebastian
| $25.25 | $160 |
534%
upside
| Neutral |
22 Nov ‘22
2 years ago |
|
790
Twist Bioscience
TWST
$1.51B
|
CS
Catherine Schulte
| $25.09 | $33 |
32%
upside
| Outperform |
21 Nov ‘22
2 years ago |
|
791
IDEAYA Biosciences
IDYA
$2.17B
|
JB
Joel Beatty
| $24.74 | $24 |
3%
downside
| Outperform |
18 Nov ‘22
2 years ago |
|
792
Ziff Davis
ZD
$1.57B
|
WP
William Power
| $38.27 | $95 |
148%
upside
| Outperform |
10 Nov ‘22
2 years ago |
|
793
Arcturus Therapeutics
ARCT
$487M
|
JB
Joel Beatty
| $17.94 | $18 |
0%
upside
| Underperform |
10 Nov ‘22
2 years ago |
|
794
Ouster
OUST
$1.65B
|
TG
Tristan Gerra
| $28.51 | $15 |
47%
downside
| Neutral |
8 Nov ‘22
2 years ago |
|
795
Lineage Cell Therapeutics
LCTX
$290M
|
JA
Jack Allen
| $1.27 | $5 |
294%
upside
| Outperform |
2 Nov ‘22
2 years ago |
|
796
Thermo Fisher Scientific
TMO
$182B
|
CR
Catherine Ramsey
| $482.41 | $665 |
38%
upside
| Outperform |
1 Nov ‘22
2 years ago |
|
797
Alphabet (Google) Class C
GOOG
$2.9T
| $239.94 | $120 |
50%
downside
| Outperform |
25 Oct ‘22
2 years ago |
|
|
798
Sabra Healthcare REIT
SBRA
$4.58B
|
DR
David Rodgers
| $19.08 | $13 |
32%
downside
| Neutral |
10 Oct ‘22
2 years ago |
|
799
Four Corners Property Trust
FCPT
$2.72B
|
WG
Wesley Golladay
| $26.01 | $27 |
4%
upside
| Outperform |
7 Oct ‘22
2 years ago |
|
800
Swvl Holdings
SWVL
$37.9M
|
BK
Ben Kallo
| $3.83 | $200 |
5,122%
upside
| Outperform |
9 Sep ‘22
3 years ago |
|